Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
US Army
Cerilliant
Julphar
Harvard Business School
UBS
Accenture
Cantor Fitzgerald
Chubb
AstraZeneca

Generated: February 23, 2018

DrugPatentWatch Database Preview

NEORAL Drug Profile

« Back to Dashboard

Which patents cover Neoral, and when can generic versions of Neoral launch?

Neoral is a drug marketed by Novartis and is included in two NDAs.

The generic ingredient in NEORAL is cyclosporine. There are seventeen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.

US Patents and Regulatory Information for NEORAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis NEORAL cyclosporine CAPSULE;ORAL 050715-001 Jul 14, 1995 AB1 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis NEORAL cyclosporine SOLUTION;ORAL 050716-001 Jul 14, 1995 AB1 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis NEORAL cyclosporine CAPSULE;ORAL 050715-003 Jul 14, 1995 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis NEORAL cyclosporine CAPSULE;ORAL 050715-002 Jul 14, 1995 AB1 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for NEORAL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis NEORAL cyclosporine CAPSULE;ORAL 050715-002 Jul 14, 1995 ➤ Sign Up ➤ Sign Up
Novartis NEORAL cyclosporine CAPSULE;ORAL 050715-003 Jul 14, 1995 ➤ Sign Up ➤ Sign Up
Novartis NEORAL cyclosporine CAPSULE;ORAL 050715-003 Jul 14, 1995 ➤ Sign Up ➤ Sign Up
Novartis NEORAL cyclosporine CAPSULE;ORAL 050715-001 Jul 14, 1995 ➤ Sign Up ➤ Sign Up
Novartis NEORAL cyclosporine SOLUTION;ORAL 050716-001 Jul 14, 1995 ➤ Sign Up ➤ Sign Up
Novartis NEORAL cyclosporine CAPSULE;ORAL 050715-001 Jul 14, 1995 ➤ Sign Up ➤ Sign Up
Novartis NEORAL cyclosporine CAPSULE;ORAL 050715-001 Jul 14, 1995 ➤ Sign Up ➤ Sign Up
Novartis NEORAL cyclosporine CAPSULE;ORAL 050715-003 Jul 14, 1995 ➤ Sign Up ➤ Sign Up
Novartis NEORAL cyclosporine SOLUTION;ORAL 050716-001 Jul 14, 1995 ➤ Sign Up ➤ Sign Up
Novartis NEORAL cyclosporine CAPSULE;ORAL 050715-003 Jul 14, 1995 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Covington
UBS
US Army
Express Scripts
Fish and Richardson
Healthtrust
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot